Management of immune-related cutaneous adverse events with dupilumab.
Kuo AM, Gu S, Stoll J, Moy AP, Dusza SW, Gordon A, Haliasos EC, Janjigian Y, Kraehenbuehl L, Quigley EA, Chapman P, Lacouture ME, Markova A.
Kuo AM, et al. Among authors: markova a.
J Immunother Cancer. 2023 Jun;11(6):e007324. doi: 10.1136/jitc-2023-007324.
J Immunother Cancer. 2023.
PMID: 37270183
Free PMC article.